Head-to-head · WeighScore
Layla vs Transcarent
The verdict
Layla takes it — 70.9/100 to 55.2/100.
Layla grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Layla is a US telehealth weight-loss program built around semaglutide, offering compounded semaglutide as injections and as oral dropper drops, plus compounded tirzepatide and a brand-inclusive GLP-1…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Layla | Transcarent |
|---|---|---|
| WeighScore | 70.9/100 | 55.2/100 |
| Grade | C | C |
| Scorecard rank | #101 | #445 |
| Semaglutide | $237/mo (all doses, compounded) | Not disclosed |
| Tirzepatide | $199/mo (all doses, compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #101 · C
Strengths
- Oral semaglutide dropper option plus injectable semaglutide and tirzepatide, with a brand-name upgrade path
- Named Medical Director (Dr. Ruth Cohen) and 24-7 doctor messaging
- Quiz-based intake with fast three to five day shipping
Where it loses points
- Brand-inclusive GLP-1 program is expensive, starting around 1,299 dollars
- States served are not published on the site
- Support phone line uses a UK format, and the compounding pharmacy is not named
Graded #445 · C
Strengths
- Comprehensive Weight Health pathway from lifestyle to GLP-1s to surgery
- Care team of doctors, nurses and pharmacists supports medication use
- Uses direct pharma contracts and a transparent PBM to cut costs
- Integrates bariatric surgery navigation alongside medication
- Built on 15 years of Surgery Center of Excellence experience
Where it loses points
- Distributed only via employers and health plans, no direct cash-pay
- GLP-1 access depends on whether the plan covers the medication
- No public individual monthly pricing
- Not available to consumers without an eligible employer or plan
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.